Literature DB >> 20093043

Meeting of the Strategic Advisory Group of Experts on immunization, October 2009--Conclusions and recommendations.

.   

Abstract

The conclusions and recommendations from the October 2009 meeting of the Strategic Advisory Group of Experts (SAGE) on immunization have been published in the WHO weekly epidemiological record (December 11, 2009) and are reproduced with the permission. Copyright 2009. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20093043     DOI: 10.1016/j.biologicals.2009.12.007

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  5 in total

1.  Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Authors:  Daniel Herrera; Camilo Vásquez; Blaise Corthésy; Manuel A Franco; Juana Angel
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

Review 2.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

Review 3.  Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.

Authors:  Daniel E Velasquez; Umesh Parashar; Baoming Jiang
Journal:  Expert Rev Vaccines       Date:  2017-12-29       Impact factor: 5.217

4.  Histo-Blood Group Antigens in Children with Symptomatic Rotavirus Infection.

Authors:  Raúl Pérez-Ortín; Susana Vila-Vicent; Noelia Carmona-Vicente; Cristina Santiso-Bellón; Jesús Rodríguez-Díaz; Javier Buesa
Journal:  Viruses       Date:  2019-04-10       Impact factor: 5.048

5.  Rotavirus symptomatic infection among unvaccinated and vaccinated children in Valencia, Spain.

Authors:  Raúl Pérez-Ortín; Cristina Santiso-Bellón; Susana Vila-Vicent; Noelia Carmona-Vicente; Jesús Rodríguez-Díaz; Javier Buesa
Journal:  BMC Infect Dis       Date:  2019-11-27       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.